Long term effects of azithromycin in patients with cystic fibrosis: a double blind, placebo controlled trial

Por Clement, A, Tamalet, A, Leroux, E, Ravilly, S, Fauroux, B, Jais, J‐P
Publicado em 2006

Alteration of lung diffusion capacity in IgA nephropathy.

Por Ravilly, S, Chaussain, M, Iniguez, J L, Lenhert, A, Kalifa, G, Brun, P, Niaudet, P, Gendrel, D
Publicado em 1996

Multicenter Study of Prevalence of Nontuberculous Mycobacteria in Patients with Cystic Fibrosis in France

Por Roux, Anne-Laure, Catherinot, Emilie, Ripoll, Fabienne, Soismier, Nathalie, Macheras, Edouard, Ravilly, Sophie, Bellis, Gil, Vibet, Marie-Anne, Le Roux, Evelyne, Lemonnier, Lydie, Gutierrez, Cristina, Vincent, Véronique, Fauroux, Brigitte, Rottman, Martin, Guillemot, Didier, Gaillard, Jean-Louis
Publicado em 2009

Reference percentiles for FEV₁ and BMI in European children and adults with cystic fibrosis

Por Boëlle Pierre-Yves, Viviani Laura, Busson Pierre-Francois, Olesen Hanne V, Ravilly Sophie, Stern Martin, Assael Baroukh M, Barreto Celeste, Drevinek Pavel, Thomas Muriel, Krivec Uros, Mei-Zahav Meir, Vibert Jean-François, Clement Annick, Mehta Anil, Corvol Harriet
Publicado em 2012-09-01

Reference percentiles for FEV(1) and BMI in European children and adults with cystic fibrosis

Por Boëlle, Pierre-Yves, Viviani, Laura, Busson, Pierre-Francois, Olesen, Hanne V, Ravilly, Sophie, Stern, Martin, Assael, Baroukh M, Barreto, Celeste, Drevinek, Pavel, Thomas, Muriel, Krivec, Uros, Mei-Zahav, Meir, Vibert, Jean-François, Clement, Annick, Mehta, Anil, Corvol, Harriet
Publicado em 2012